Epigenetics & Chromatin

official impact factor 4.73

Open Access Highly Access Research

Generation of bivalent chromatin domains during cell fate decisions

Marco De Gobbi1, David Garrick1, Magnus Lynch1, Douglas Vernimmen1, Jim R Hughes1, Nicolas Goardon1, Sidinh Luc2, Karen M Lower1, Jacqueline A Sloane-Stanley1, Cristina Pina1, Shamit Soneji1, Raffaele Renella1, Tariq Enver1, Stephen Taylor3, Sten Eirik W Jacobsen2, Paresh Vyas1,4, Richard J Gibbons1 and Douglas R Higgs1*

Author Affiliations

1 MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK

2 Haemopoietic Stem Cell Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 9DS, UK

3 Computational Biology Research Group (CBRG), University of Oxford, Oxford, UK

4 Department of Haematology, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK

For all author emails, please log on.

Epigenetics & Chromatin 2011, 4:9 doi:10.1186/1756-8935-4-9

Published: 6 June 2011

Abstract

Background

In self-renewing, pluripotent cells, bivalent chromatin modification is thought to silence (H3K27me3) lineage control genes while 'poising' (H3K4me3) them for subsequent activation during differentiation, implying an important role for epigenetic modification in directing cell fate decisions. However, rather than representing an equivalently balanced epigenetic mark, the patterns and levels of histone modifications at bivalent genes can vary widely and the criteria for identifying this chromatin signature are poorly defined.

Results

Here, we initially show how chromatin status alters during lineage commitment and differentiation at a single well characterised bivalent locus. In addition we have determined how chromatin modifications at this locus change with gene expression in both ensemble and single cell analyses. We also show, on a global scale, how mRNA expression may be reflected in the ratio of H3K4me3/H3K27me3.

Conclusions

While truly 'poised' bivalently modified genes may exist, the original hypothesis that all bivalent genes are epigenetically premarked for subsequent expression might be oversimplistic. In fact, from the data presented in the present work, it is equally possible that many genes that appear to be bivalent in pluripotent and multipotent cells may simply be stochastically expressed at low levels in the process of multilineage priming. Although both situations could be considered to be forms of 'poising', the underlying mechanisms and the associated implications are clearly different.